Jiangsu Yahong Pharmaceutical Technology Co.
Latest round
- Series D
Last raised
- Nov 2020
Total raised
- $176M
Investors
- 27
About Jiangsu Yahong Pharmaceutical Technology Co.
, Ltd. is a pharmaceutical company that focuses on the research and development of urogenital oncology drugs. In 2018, the company established the Shanghai R&D Center. The company has offices in Beijing and Taizhou. In 2022, the company was listed on the Shanghai Stock Exchange. Its stock code was 688176. Dr. Ke Pan, the founder, chairman and CEO of the company, once founded Hutchison Whampoa (Shanghai) Pharmaceuticals and served as the senior director and senior director of new medicinal chemistry research and patent protection. The company engages in the research and development of urogenital oncology drugs. Its main products include Vishco APL-1202, Hackway APL-1706 and Xiweita APL-1702, etc. The company's products are used in urinary system diseases and reproductive system diseases.
Who invested in Jiangsu Yahong Pharmaceutical Technology Co.
27 investors across 5 rounds
See all investors in Jiangsu Yahong Pharmaceutical Technology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Jiangsu Yahong Pharmaceutical Technology Co.
Who invested in Jiangsu Yahong Pharmaceutical Technology Co.?
Jiangsu Yahong Pharmaceutical Technology Co. has 27 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Jiangsu Yahong Pharmaceutical Technology Co. raised?
Jiangsu Yahong Pharmaceutical Technology Co. has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Jiangsu Yahong Pharmaceutical Technology Co. last raise money?
Jiangsu Yahong Pharmaceutical Technology Co.'s most recent round on record is a Series D, in Nov 2020.
What does Jiangsu Yahong Pharmaceutical Technology Co. do?
Jiangsu Yahong Pharmaceutical Technology Co. is a biotechnology company.
Where is Jiangsu Yahong Pharmaceutical Technology Co. headquartered?
Jiangsu Yahong Pharmaceutical Technology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Jiangsu Yahong Pharmaceutical Technology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Jiangsu Yahong Pharmaceutical Technology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Jiangsu Yahong Pharmaceutical Technology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.